Clinical Manufacturing of Tumor-Infiltrating Lymphocytes (TIL): Combining TIL Outgrowth and Rapid Expansion On A Closed and Automated Platform.
2025 · Cytotherapy · 0 citations
https://doi.org/10.1016/j.jcyt.2025.03.362
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
7
Citations
1
h-index
0
i10-index
Mike Dienstbier is an academic researcher from Miltenyi Biotec (Germany). The author has contributed to research in topics: 3D Printing in Biomedical Research & CAR-T cell therapy research & Cancer Cells and Metastasis. The author has an h-index of 1, co-authored 2 publications.
Click to start Chat